Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A Novel Heterozygous NFKB2 Variant in a Multiplex Family with Common Variable Immune Deficiency and Autoantibodies Against Type I IFNs

Journal of Clinical Immunology(2024)10.1007/s10875-024-01843-1Source: DataRank Database

A Novel Heterozygous NFKB2 Variant in a Multiplex Family with Common Variable Immune Deficiency and Autoantibodies Against Type I IFNs is a research paper published in Journal of Clinical Immunology (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.45)OA: bronzeTopics (79)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Aysima Atılgan Lülecioğlu,Liwei Gao,Yılmaz Yücehan Yazıcı,Fevzi Demirel ORCID,Ayşe Metìn ORCID

Live enrichment

PubMed:39579251 PMC:PMC11821294 OpenAlex:https://openalex.org/W4404641956

NCATS NIH HHS

Grant: UL1 TR001866

NIAID NIH HHS

Grant: R01 AI163029

National Institutes of Health

Grant: 5UL1TR001866-07

Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success

French National Research Agency (ANR)

Grant: ANR-22-CE15-0046

Autoantibodies against Interferons underlying Infectious Diseases

European Commission

Grant: 101057100

The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infection: Towards personalised medicine

National Institutes of Health

Grant: 5R01AI163029-04

Inborn errors of immunity in patients with life-threatening COVID-19

Howard Hughes Medical Institute

FWCI

0.45

Citation Percentile

0.6%

Citation Trend

2025

2026

bronzeLicense: Springer Nature TDM

journalhttps://link.springer.com/content/pdf/10.1007/s10875-024-01843-1.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s10875-024-01843-1.pdf

publisherhttps://link.springer.com/article/10.1007/s10875-024-01843-1

journalhttps://doi.org/10.1007/s10875-024-01843-1

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39579251

Fields of Study

Immunodeficiency and Autoimmune DisordersNF-κB Signaling PathwaysImmune Cell Function and Interaction03 medical and health sciences0303 health sciencesAdultFemaleHumansMaleMiddle AgedAllelesAutoantibodiesCommon Variable ImmunodeficiencyCOVID-19Genetic Predisposition to DiseaseHeterozygoteInterferon Type IMutation, MissenseNF-kappa B p52 SubunitPedigreeSARS-CoV-2Signal Transduction

MeSH Terms

COVID-19SARS-CoV-2AdultAllelesAutoantibodiesFemaleHeterozygoteHumansInterferon Type IMaleMiddle AgedPedigreeSignal TransductionCommon Variable ImmunodeficiencyGenetic Predisposition to DiseaseMutation, MissenseNF-kappa B p52 Subunit

Keywords

Common variable immunodeficiencyImmunologyAutoantibodyBiologyMissense mutationPrimary immunodeficiencyImmune systemAlleleHypogammaglobulinemiaImmune dysregulationPhenotypeAntibodyGeneticsGeneType I interferonsWhole-exome SequencingCommon Variable Immune DeficiencyNf-κb2Neutralizing AutoantibodiesInborn Error Of ImmunityAlternative Nf-κb Signaling PathwayAdultMaleHeterozygoteImmune deficiencyMutation, MissenseArticleNF-kappa B p52 SubunitHumansGenetic Predisposition to DiseaseAllelesAutoantibodiesSARS-CoV-2COVID-19Middle AgedPedigreeInterferon Type ICommon variableFemaleSignal Transduction

Sustainable Development Goals

SDG 0: Zero hunger

A Novel Heterozygous NFKB2 Variant in a Multiplex Family with Common Variable Immune Deficiency and Autoantibodies Against Type I IFNs

FAIR Checklist

Authors (11)

Funding (8 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)